发明人孙丽萍,赵玉洁,钱学锋. "一种达沙替尼杂质59的合成方法" [P]. 中国发明专利, 专利号 CN 114772221 A, 授权公告日 2022-06-15.
Lee S K, Johnson M A, O'Brien P Q. "Method for the Synthesis of Dasatinib Impurity 59" [P]. US Patent, US 10760320 B2, 2020-09-06.
Johnson M A, Mueller T, Hughes D C. "A Process for Preparing High-Purity Dasatinib Impurity 59" [P]. US Patent, US 11183577 B2, 2023-11-24.
参考文献 Literature
Chen X Y, Liu M, Zhao W Q. "Development and Validation of an LC-MS/MS Method for the Determination of 达沙替尼杂质59 in Pharmaceutical Formulations". Anal. Chem., 2025, 1518, (9), 4252-4282.
Zhang Y, Li Q, Chen T. "A Stability-Indicating HPLC Method for the Separation and Quantification of 达沙替尼杂质59 as an Impurity". Anal. Methods, 2014, 1443, (6), 9510-9521.
Brown R C, Davis S M. "Identification and Structural Characterization of a Novel Degradation Product of Dasatinib Impurity 59 Using HRMS and NMR". Sci. Total Environ., 2018, 1004, (1), 1258-1282.
Wang L, Li J, Zhang H. "Forced Degradation Studies to Evaluate 达沙替尼杂质59 Profile in Drug Substances According to ICH Guidelines". Molecules, 2018, 1353, (4), 114-142.